Last reviewed · How we verify

NCT03927612

Virtual Reality to Improve Social Perspective Taking

Completed NA Results posted Last updated 28 June 2023
What this trial tests

NA trial testing Virtual reality perspective taking training in Conduct Disorder in 90 participants. Completed in 30 March 2022.

Timeline
7 January 2020
Primary endpoint
30 March 2022
30 March 2022

Quick facts

Lead sponsorIndiana University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment90
Start date7 January 2020
Primary completion30 March 2022
Estimated completion30 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University

Who can join

Adults 9 to 12, any sex, with Conduct Disorder or Child. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change From Pre-intervention on the Virtual Reality Perspective Taking Scale Primary · 1 Day

This scale provides a 0-100 score that indicates the degree to which participants understand the perspective of their virtual counterpart, derived from the Perspective Taking subscale of the Interpersonal Reactivity Index. A higher change score indicate greater improvement in perspective taking in the virtual environment. The scale will be completed twice on the same day, before and after the intervention.

GroupValue95% CI
Alternate Perspective16.3± 27.9
Control Perspective-10.4± 26.3
Change From Pre-intervention on the Acknowledgement of Other Perspective Scale Primary · 1 Day

This scale allows participants to rate the relative importance of the virtual counterpart's perspective, on a 0-100 scale, with a scenario-specific question. A higher change score indicates greater improvement in acknowledging the virtual counterpart's perspective. The scale will be completed twice on the same day, before and after the intervention.

GroupValue95% CI
Alternate Perspective2.0± 27.1
Control Perspective-1.4± 18.5
Change From Pre-intervention in Brain Activity in Response to Self Pain vs. Other Pain Primary · The fMRI scans will be administered 0-2 weeks prior to the intervention and the day of the intervention (upon completion of the intervention).

Functional magnetic resonance imaging (fMRI) will measure the blood-oxygen level-dependent (BOLD) response in the dorsal anterior cingulate cortex, left anterior insula, and right anterior insula while imagining pain happening to oneself or the virtual counterpart. Perspective taking and empathy are reflected by a similar BOLD response to self and other pain. This score reflects the change from baseline in the Self Pain - Other Pain contrast in each region. A lower score to Self vs. Other pain results from a stronger response to other's pain, reflecting improved perspective taking. Therefore,

Left Anterior Insula Change
GroupValue95% CI
Alternate Perspective0.089± 0.19
Control Perspective-0.070± 0.25
Right Anterior Insula Change
GroupValue95% CI
Alternate Perspective0.078± 0.22
Control Perspective-0.128± 0.30
Dorsal Anterior Cingulate Cortex Change
GroupValue95% CI
Alternate Perspective0.10± 0.27
Control Perspective-0.080± 0.34

Sponsor's own description

This project will examine how virtual reality treatment that provides users with the alternate perspective of a virtual interpersonal interaction impacts psychological and neurobiological markers of social perspective taking in children with a disruptive behavior disorder. The investigators anticipate that experiencing a virtual encounter from a counterpart's point-of-view improves a child's perspective taking and alters brain function related to imagining another person's pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Conduct Disorder

Currently open trials in the same condition.

Other Indiana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03927612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing